Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010-2015).

about

Value Added by the Prevnar 13 Childhood Immunization Program in Alberta, Canada (2010-2015).

Item

http://www.wikidata.org/entity/Q36942925

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Value Added by the Prevnar 13 ...... n Alberta, Canada (2010-2015).

@en

type

Item

label

Value Added by the Prevnar 13 ...... n Alberta, Canada (2010-2015).

@en

prefLabel

Value Added by the Prevnar 13 ...... n Alberta, Canada (2010-2015).

@en

P1476

Value Added by the Prevnar 13 ...... n Alberta, Canada (2010-2015).

@en

P2093

Anderson W Chuck

http://www.w3.org/2001/XMLSchema#string

Arianna Waye

http://www.w3.org/2001/XMLSchema#string

P2860

Efficacy, safety and immunogenicity of heptavalent pneumococcal conjugate vaccine in children. Northern California Kaiser Permanente Vaccine Study Center Group.

Serotype-specific changes in invasive pneumococcal disease after pneumococcal conjugate vaccine introduction: a pooled analysis of multiple surveillance sites.

The burden of pneumococcal disease in the Canadian population before routine use of the seven-valent pneumococcal conjugate vaccine.

Effect of use of 13-valent pneumococcal conjugate vaccine in children on invasive pneumococcal disease in children and adults in the USA: analysis of multisite, population-based surveillance

Advances in pneumococcal disease prevention: 13-valent pneumococcal conjugate vaccine for infants and children.

Streptococcus pneumoniae infection: a Canadian perspective.

Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine.

The epidemiology of invasive pneumococcal disease in British Columbia following implementation of an infant immunization program: increases in herd immunity and replacement disease.

Cost trajectories at the end of life: the Canadian experience.

Changing Epidemiology of Invasive Pneumococcal Disease in Canada, 1998–2007: Update from the Calgary‐AreaStreptococcus pneumoniaeResearch (CASPER) Study

P2888

s40801-015-0037-2

P304

311-318

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S40801-015-0037-2

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-09-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282521731

http://www.w3.org/2001/XMLSchema#string

P698

27747577

http://www.w3.org/2001/XMLSchema#string

P932

4883219

http://www.w3.org/2001/XMLSchema#string